Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Scientists have developed Rhobo6, a light microscopy probe that reveals extracellular matrix structures in live tissues, ...

Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...